M3, Inc. (4YC.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 05:15PM CEST
| Previous close | 10.40 |
| Open | 9.80 |
| Bid | 9.90 x N/A |
| Ask | 10.50 x N/A |
| Day's range | 9.75 - 9.80 |
| 52-week range | 9.25 - 21.80 |
| Volume | |
| Avg. volume | 36 |
| Market cap | 6.654B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.26 (2.47%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
M3 WAKE RESEARCH EXPANDS INTO CHARLESTON, SC
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.
© 2024 Yahoo. All rights reserved.